“…Recent research on the neurobiology of major depression has also focused on the ACC. More specifically, the major depression symptom of anhedonia, characterized by reward-insensitive behavior and blunted positive emotionality -and hence, apparently, the extremely low end of aE (Depue, 1995) -has been associated with abnormally low levels of activity in the ventral-rostral ACC (rACC) regions (Pizzagalli, Peccoralo, Davidson, & Cohen, 2006) and with blunted nucleus accumbens responses to reward signals (Wacker, Dillon, & Pizzagalli, 2009). Furthermore, pharmacological challenge studies have demonstrated that the ACC responds to dopaminergic drugs (e.g., Völlm et al, 2004), and ACC activity also qualifies as a predictor for psychopharmacological treatment responses (for selective norepinephrine and serotonin reuptake inhibitors, see Korb, Hunter, Cook, & Leuchter, 2009).…”